Rising Demand for Stent Retrievers
Stent retrievers are second-generation mechanical thrombectomy products utilized for the treatment of thrombotic disorders. The increasing prevalence of cardiovascular disease because of increase in alcohol consumption, smoking, stress and unhealthy foods and growing aging population across the world, are propelling the clot management device market growth during the forecast period. One of the important factors that drive the market growth is the increasing availability of reimbursement of thrombectomy procedures, rising public and private investments for product development and commercialization and increasing patient emphasis with minimally invasive procedure. Ongoing drug developments by leading companies and expansion of the presence in emerging countries by the market players through the establishment of manufacturing facilities, research and development facilities and distribution networks are the important factors that significantly contribute to the growth of the clot management devices market during the forecast period.
Increasing Availability of Medical Reimbursements
With continued technical breakthroughs in the field of minimally invasive operations, thrombectomy systems are currently being used in hospitals and surgical centres in collaboration with diagnostic technologies for image-guided thrombectomy procedures. The frequency of thrombectomy procedures performed in hospitals and surgical centres is rising due to the increased use of stent and clot retrievers in treating acute ischemic stroke and the rising incidence of chronic vascular illnesses. Apart from this, main market players are focusing on research and development sector to create an advance technology in thrombectomy devices. Major players are collaborating with academic and research institutes to get the support on their ongoing clinical projects and rising public private funding to support research projects in the field of thrombectomy to develop novel thrombectomy technology, which is expected to drive the overall clot management device market growth during the forecast period.
Download Free Sample Report
MarketSegmentation
Global Clot Management Devices market issegmented on the basis of product type, end user, and region. Based on product type,the market can be segmented into neurovascular embolectomy devices, embolectomyballoon catheters, percutaneous thrombectomy devices, catheter directedthrombolysis devices, and others. Based on end user, the market can be segmentedinto hospitals & clinics, ambulatorycare centers, and others. Regionally, Europe dominated the market among AsiaPacific, North America, Middle East & Africa and South America. In termsof country, the United States is dominating the global clot management devicesmarket. This can be ascribed to the increasing cost-effective devices in thehealthcare sector. According to the World Health Organization (WHO), the number ofpeople suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) ismuch larger than people suffering from AIDS and cancer. During the year 2015,around 9,00,000 people were diagnosed with DVT & PE in the United States.
Market Players
Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward LifeSciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated are some of the leading players operating in the Global Clot Management Devices Market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2022 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in Units, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | By Product Type By End User By Region |
| Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
| Country scope | United States, Mexico, Canada, France, Germany, United Kingdom, Italy, Spain, China, India, South Korea, Japan, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE, Egypt, Turkey |
| Key companies profiled | Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward LifeSciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
